OPA Marijuana Survey. Summary of 2016 survey results
|
|
|
- Dominick Anthony
- 5 years ago
- Views:
Transcription
1 OPA Marijuana Survey Summary of 2016 survey results
2 Respondent Summary Total response = 671 pharmacists All membership categories and postal code districts 25% staff pharmacists 25% owners or designated managers 15% pharmacy students Good uptake within community pharmacy 29% from independent pharmacies 35% from chain/banner pharmacies 40% of respondents in practice > 21 yrs 20% of respondents in practice < 5 yrs
3 Marijuana - Medicinal
4 When considering the use of marijuana for medical purposes, I believe that Marijuana should be legalized for medicinal use 4.2% 7.5% 43.5% Strongly 36.7% Need More Info 8.1% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0%
5 When considering the use of marijuana for medical purposes, I believe that Marijuana is safe when used responsibly for medical purposes 3.0% 7.2% 44.6% Strongly 28.6% Need More Info 16.6% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0%
6 When considering the use of marijuana for medical purposes, I believe that People who call for the legalization of medical marijuana are drug abusers 28.9% 52.0% 8.0% Strongly 2.8% Need More Info 8.2% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0%
7 When considering the use of marijuana for medical purposes, I believe that Legalizing medical marijuana would cause crime rates to increase 26.7% 44.8% Strongly 6.0% 8.5% Need More Info 14.0% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0%
8 When considering the use of marijuana for medical purposes, I believe that Medical marijuana should be classified as a "drug" with a DIN and should be dispensed by pharmacists in accordance with regulations in place for all narcotic and controlled drugs 10.2% 10.7% 24.0% Strongly 43.0% Need More Info 12.2% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0%
9 When considering the use of marijuana for medical purposes, I believe that The sale of medical marijuana in pharmacies will put the safety of pharmacy personnel at risk 20.3% 37.7% Strongly 15.2% 17.7% Need More Info 9.2% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0%
10 With respect to my comfort in the clinical aspects of medical marijuana, I believe that I am knowledgeable on the subject of medical marijuana 9.9% 43.4% 39.7% Strongly 7.0% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0%
11 With respect to my comfort in the clinical aspects of medical marijuana, I believe that I am comfortable answering questions from patients about the efficacy of medical marijuana 13.9% 44.2% 35.1% Strongly 6.9% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0%
12 With respect to my comfort in the clinical aspects of medical marijuana, I believe that I am comfortable answering questions from patients about the safety of medical marijuana 13.0% 43.0% 36.0% Strongly 8.0% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0%
13 With respect to my comfort in the clinical aspects of medical marijuana, I believe that I am comfortable answering questions from patients about drug interactions related to medical marijuana 20.0% 48.1% 25.5% Strongly 6.3% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0%
14 With respect to my comfort in the clinical aspects of medical marijuana, I believe that Medical marijuana should only be prescribed and dispensed by approved healthcare professionals (i.e. through credentialing) 3.2% 8.4% 43.1% Strongly 45.4% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0%
15 With respect to my comfort in the clinical aspects of medical marijuana, I believe that I can separate my personal opinions on medical marijuana and effectively counsel and advise patients on its use 2.8% 6.5% 49.4% Strongly 41.2% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0%
16 With respect to my comfort in the clinical aspects of medical marijuana, I believe that I would benefit from a continuing education program on medical marijuana 1.2% 3.7% 37.9% Strongly 57.3% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0% 70.0%
17 Notwithstanding any remuneration model, do you believe that pharmacies should be involved with the sale and/or distribution of medical marijuana? Axis Title 80.0% 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% Yes No Undecided BANNER/INDEP 70.3% 13.8% 15.9% CHAIN 67.6% 20.0% 12.4% STAFF P'CIST 54.9% 27.2% 17.9% STUDENT 72.7% 13.6% 13.6% BLENDED 63.9% 19.6% 16.9%
18 To your knowledge, are any of your patients currently being treated with medical marijuana? Yes 48.4% No 51.6% 46.0% 47.0% 48.0% 49.0% 50.0% 51.0% 52.0%
19 Has your interaction with this/these patients affected your perceptions of medical marijuana therapy? (No) Perceptions stayed the same 64.0% (Yes) More positive opinion 32.2% (Yes) Less positive opinion 3.8% 0.0% 20.0% 40.0% 60.0% 80.0%
20 Marijuana - Recreational
21 When considering the use of marijuana for recreational purposes, I believe that Marijuana should be legalized for the general population 24.2% 24.6% 29.5% Strongly Need More Info 11.6% 10.2% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0%
22 When considering the use of marijuana for recreational purposes, I believe that Marijuana is safe for recreational use when used responsibly 20.1% 24.2% 35.4% Strongly 8.4% Need More Info 11.9% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0%
23 When considering the use of marijuana for recreational purposes, I believe that Legalizing marijuana for recreational use will cause crime rates to increase 20.6% 41.0% Strongly 11.3% 10.6% Need More Info 16.6% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0%
24 When considering the use of marijuana for recreational purposes, I believe that The sale of marijuana for recreational use is best done through community pharmacies as a behind-the-counter product 32.5% 26.8% Strongly 15.8% 14.7% Need More Info 10.2% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0%
25 When considering the use of marijuana for recreational purposes, I believe that The sale of marijuana for recreational use through pharmacies will undermine the image of a pharmacy as a health centre and/or tarnish the credibility of the pharmacist as a health professional 13.9% 21.3% 23.6% Strongly 31.0% Need More Info 10.1% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0%
26 When considering the use of marijuana for recreational purposes, I believe that The sale of marijuana for recreational use through pharmacies will put the safety of pharmacy personnel at risk 15.3% 30.8% Strongly 21.6% 22.9% Need More Info 9.5% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0%
27 When considering the use of marijuana for recreational purposes, I believe that The sale of marijuana for recreational use through pharmacies will generate tremendous business opportunities 9.4% 18.6% 34.1% Strongly 21.7% Need More Info 16.3% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0%
28 With respect to my comfort in the clinical aspects of recreational marijuana, I believe I am knowledgeable on the subject of recreational marijuana 15.5% 42.3% 37.3% Strongly 4.9% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0%
29 With respect to my comfort in the clinical aspects of recreational marijuana, I believe I am comfortable answering questions from patients about marijuana for recreational use 17.1% 43.4% 33.3% Strongly 6.2% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0%
30 With respect to my comfort in the clinical aspects of recreational marijuana, I believe I am comfortable answering questions from patients about the safety of marijuana 14.8% 40.5% 38.6% Strongly 6.2% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0%
31 With respect to my comfort in the clinical aspects of recreational marijuana, I believe I am comfortable answering questions from patients about drug interactions related to marijuana 19.5% 48.6% 26.6% Strongly 5.3% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0%
32 With respect to my comfort in the clinical aspects of recreational marijuana, I believe Marijuana should only be dispensed by approved healthcare professionals (i.e. through credentialing) 9.2% 18.5% 42.3% Strongly 30.1% 0.0% 5.0% 10.0% 15.0% 20.0% 25.0% 30.0% 35.0% 40.0% 45.0%
33 With respect to my comfort in the clinical aspects of recreational marijuana, I believe I can separate my personal opinions on marijuana and effectively counsel and advise patients on its use 3.5% 10.6% 56.3% Strongly 29.6% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0%
34 With respect to my comfort in the clinical aspects of recreational marijuana, I believe I would benefit from a continuing education program on marijuana 1.8% 4.6% 42.1% Strongly 51.6% 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0%
35 Notwithstanding any remuneration model, do you believe that pharmacies should be involved with the sale and/or distribution of medical marijuana? 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% Yes No Undecided BANNER/INDEP 39.6% 43.4% 17.0% CHAIN 33.1% 46.6% 20.3% STAFF P'CIST 26.0% 56.1% 17.9% STUDENT 35.4% 37.8% 26.8% BLENDED 32.0% 49.0% 19.0%
Community Pharmacy Practice in Norway
Community Pharmacy Practice in Norway Contributed by: Cand.pharm. Rønnaug Larsen, President, The Norwegian Association of Pharmacists Norwegian facts - Kingdom with parliamentary democracy. - Population
MINNESOTA S MEDICAL CANNABIS PROGRAM
MINNESOTA S MEDICAL CANNABIS PROGRAM DARIN TESKE LEGAL AND POLICY ADVISOR OFFICE OF MEDICAL CANNABIS AUGUST 25, 2016 2014: MN became 22 nd state with full medical cannabis program Recreational and Medical
Dispensing and administration of emergency opioid antagonist without a
68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies
JAMESTOWN COMMUNITY SCHOOL DRUG POLICY
JAMESTOWN COMMUNITY SCHOOL DRUG POLICY It is expected that all members of the school community are aware of the guidelines in this policy to ensure the safe use of drugs within the school. WHAT IS A DRUG?
Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients
Non-Prescription Medicinal Products Containing Codeine: Guidance for Pharmacists on Safe Supply to Patients Pharmaceutical Society of Ireland Version 3 October 2017 Updates made following the enactment
Evidence-Based Clinical Practice Guideline. Treatment & Management of Ocular Disease
Evidence-Based Clinical Practice Guideline Treatment & Management of Ocular Disease Effective November 29, 2017 Treatment & Management Of Ocular Disease Clinical Practice Guideline The objective of this
DRUG-FREE AND ALCOHOL-FREE WORK PLACE
DRUG-FREE AND ALCOHOL-FREE WORK PLACE The following applies to all employees: 1. The Gloucester County Public School System has a vital interest in maintaining a safe, healthy, and productive environment
Potential Solutions to Epidemic Substance Abuse in US and Europe
Potential Solutions to Epidemic Substance Abuse in US and Europe Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center, Denver Health 1 Professor, University of Colorado School of Medicine
Sub. S.B. 119 As Passed by the Senate
AM3404 Sub. S.B. 119 As Passed by the Senate Topic: Opioid Data and Communication Expansion Act moved to amend as follows: In line 1 of the title, after "4723.52," insert "4729.01, 4729.44, 4729.75, 4729.79,
British Columbia Pharmacy Association
British Columbia Pharmacy Association Suite 1530-1200 West 73rd Avenue Vancouver, BC V6P 6G5 Tel: 604 261-2092 Fax: 604 261-2097 info@bcpharmacy.ca www.bcpharmacy.ca October 23, 2017 Lisa Anderson Executive
The Legalization of Medical Marijuana and the Impact on the Workplace
The Legalization of Medical Marijuana and the Impact on the Workplace Presented by Cassandra L. Manna Thursday, October 12, 2017 Roetzel & Andress LPA 2016 Before We Get Started... Three Rules Supreme
The Effects of Marijuana Legalization on Schools
The Effects of Marijuana Legalization on Schools Property and Casualty Coverage for Education (PACE) Conference Marilee Scarbrough In-House Legal Counsel, Vancouver Public Schools April 21, 2016 Objectives
January 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9
January 19, 2018 Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9 By email: cannabis@canada.ca RE: Proposed Approach to the Regulation of Cannabis
Like others here today, we are very conflicted on the FDA s proposal on behind-thecounter medications, but thank you for raising the issue.
Statement of Consumers Union William Vaughan, Senior Policy Analyst before the US Food and Drug Administration Public Meeting on Behind the Counter Availability of Drugs November 14, 2007 Consumers Union
Human Resources All Personnel BP 4020 DRUG AND ALCOHOL-FREE WORKPLACE
BP 4020 DRUG AND ALCOHOL-FREE WORKPLACE The Governing Board believes that the maintenance of drug and alcohol-free workplaces is essential to school and district operations. No employee shall unlawfully
Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)
Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit
Jūratė Švarcaitė Pharmaceutical care programmes manager, Nemuno vaistinė
Forum for innovators: Pharmaceutical services implementation Successes and outcomes case study from Lithuania Title: 74 th FIP World Congress of Pharmacy and Pharmaceutical Sciences Chairs: Jūratė Švarcaitė
From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016
From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016 OSBA leads the way to educational excellence by serving Ohio s public
SEL3CT Data Presentation
SEL3CT Data Presentation Opioid Prevention Planning Grant Allison Howland & Nicole Zautra November 20, 2015 Goals of Data Collection Want to gear SEL3CT towards regional approach, utilizing each county
What Hospice Providers Want to Know about Medical Cannabis
What Hospice Providers Want to Know about Medical Cannabis Kelly S. Mendoza, MS, PharmD 1 Russell Hilliard, PhD, LCSW, LCAT, MT-BC, CHRC 2 Mary Lynn McPherson, PharmD, MA, BCPS, CPE 1 1 University of Maryland
New Ulm Public Schools
I. PURPOSE The school board recognizes that chemical use and abuse constitutes a grave threat to the physical and mental wellbeing of students and employees and significantly impedes the learning process.
Thomas Reagan. Law Enforcement Liaison Maine Bureau of Highway Safety Retired DRE
Thomas Reagan Law Enforcement Liaison Maine Bureau of Highway Safety Retired DRE Maine Marijuana (cannabis) was prohibited in 1913 2.5 ounces decriminalized in 1976 (civil) Medical Marijuana law was passed
PERSONAL HISTORY What are your strengths? (i.e. skills, positive qualities or characteristics) Hobbies/Extracurricular Activities (Please list): ETHNI
Date of Assessment ADULT PSYCHOSOCIAL HISTORY/INITIAL THERAPY INTAKE FORM Identifying Information: Name: Address: Age: D.O.B: Phone Number: Race: Gender: Religious Affiliation(optional): Current Household
Addictive Disorders Assessment Form
Addictive Disorders Assessment Form Thorpe Recovery Centre Telephone: 780.875.8890 Fax: 780.875.2161 Email: info@thorperecoverycentre.org CLIENT INFORMATION First Name Middle Name Last Name Phone Number
DAWN. In 2009, nearly 4.6 million emergency
Drug Abuse Warning Network The DAWN Report December 28, 2010 Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits In Brief In 2009, there were nearly
In 2009, nearly 4.6 million emergency
Drug Abuse Warning Network The DAWN Report December 28, 2010 Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits In Brief In 2009, there were nearly
GST ON THE SALE OF MEDICAL MARIJUANA. Jamie Nguyen, CPA, CA
GST ON THE SALE OF MEDICAL MARIJUANA Jamie Nguyen, CPA, CA Tax Partner, Davidson & Company LLP jnguyen@davidson co.com Legislation Under the Excise Tax Act ( ETA ), a supplier in Canada is required to
Provider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting
Provider Education & Utilization Initiatives Alliance of States with PMPs East Regional Meeting Baltimore, MD April 5, 2011 Massachusetts Department of Public Health MA Prescription Monitoring Program
Pharmacists in Canada A national survey of Canadians on their perceptions and attitudes towards pharmacists in Canada.
in Canada A national survey of Canadians on their perceptions and attitudes towards pharmacists in Canada. February 2015 Prepared for the Canadian Association Methodology Online Survey Sample Size Survey
The Wisconsin Prescription Drug Monitoring Program
The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing
Role of the Pharmacist in the Provision of Immunization Services
Role of the Pharmacist in the Provision of Immunization Services Susan Bowles, PharmD, MSc, FCCP Dalhousie University Capital District Health Authority Conflict of Interest Received speaking honorarium
ALLEGANY COUNTY HEROIN & OPIOID ABUSE AD HOC COMMITTEE March 9, 2017 NOT APPROVED
ALLEGANY COUNTY HEROIN & OPIOID ABUSE AD HOC COMMITTEE NOT APPROVED Committee Members Present: J. Hopkins (Chairman), L. Ballengee, V. Grant, K. LaForge, W. Penman, B. Riehle, (Absent: M. Biddle, A. Bucholz,
Donald K. Hallcom, Ph.D. March 13, 2014
Donald K. Hallcom, Ph.D. March 13, 2014 DMHAS Regional Coalitions Atlantic and Cape May Counties Cape Assist Bergen County The Center for Alcohol and Drug Resources Burlington County Prevention Plus Camden
I am pleased to highlight for this Honourable House and the public. that today the Government will be laying amendments to the
MINISTERIAL STATEMENT TO THE HOUSE OF ASSEMBLY BY THE HONOURABLE KIM N. WILSON, JP, MP MINISTER OF HEALTH UPDATES AND MODERNIZATION OF DRUG SCHEDULES 24 November 2017 Mr Speaker and Honourable Members,
The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.
The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp
Seeing some media coverage. Following it in the news
Yes, make No, should remain il Following Sample size 1510 975 535 377 649 378 106 1026 484 Regional sample sizes are unweighted. All other sample sizes, including totals, are weighted to census data. Blank
Controlled Substances: A survey of tools and resources required by hospital pharmacists
Controlled Substances: A survey of tools and resources required by hospital pharmacists TABLE OF CONTENTS 2018. Canadian Society of Hospital Pharmacists About the survey 1 The Short and Snappy 1 What CSHP
This Frequently Asked Questions document contains various aspects of UIIP in the following sections. Overview Eligibility...
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Frequently Asked Questions for Pharmacists October 2017: Pharmacist Administration of the Publicly Funded Influenza Vaccine and Claims
To assist the District in its goal to prevent chemical use and abuse by providing procedures for education and intervention.
Adopted: April 23, 1985 Revised: April 13, 1998 November 10, 2003 July 12, 2010 February 22, 2016 [Mandatory/Routine Review/MSBA Model Policy Modified] Contact Person: Executive Director Learning Supports
ACCESS TO NON-PRESCRIPTION MEDICINES THE KEY ROLE OF PHARMACY IN SELF-CARE
ACCESS TO NON-PRESCRIPTION MEDICINES THE KEY ROLE OF PHARMACY IN SELF-CARE GIRP Position Paper 1. Background Non-prescription medicines (NPMs), also referred to as Over-the-Counter medicines (OTCs), are
Drug and Alcohol Policy
Drug and Alcohol Policy 5/15 Salesyard Road Otahuhu 1062 Auckland New Zealand Ph: (09) 271 0017 Drug and Alcohol Policy ADT Contractor Ltd ADT Contractor Ltd is committed to creating a drug and alcohol
Administration of Medication
Administration of Medication Prescribed medications must arrive in a container with the original, unaltered prescription label attached. The label must display all legal information required for a pharmacist
*REVISED JANUARY 2018*
*REVISED JANUARY 2018* and Taxation of Marijuana Act (Chapter 334 of the Acts of 2016), allowing non-medical (also known as adult or recreational ) use of marijuana by adults in the Commonwealth and authorizing
Views of general practitioners and pharmacists on the role of the pharmacist in HIV/Aids management
Views of general practitioners and pharmacists on the role of the pharmacist in HIV/Aids management Van der Walt E, BPharm, MSc (Med) (MEDUNSA), PhD (MEDUNSA) Previously a postgraduate student at the School
Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business
Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business to Facilitate Compliance with Regulations 5(1)(g), 6, 8 and 11 of the Regulation of Retail Pharmacy Businesses
Initial Clinical History and Physical Form
601 E FM 544, Suite 400, Murphy, TX, 75094 TEL: 972-442-4700 Initial Clinical History and Physical Form Patient Information Name: Age: of Birth: / / Sex: Male / Female Marital Status: Single Married Divorced
H 7816 S T A T E O F R H O D E I S L A N D
LC00 01 -- H 1 S T A T E O F R H O D E I S L A N D IN GENERAL ASSEMBLY JANUARY SESSION, A.D. 01 A N A C T RELATING TO BUSINESSES AND PROFESSIONS - PHARMACIES Introduced By: Representatives Serpa, Canario,
Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business
Draft Guidelines on the Sale and Supply of Non- Prescription Medicinal Products from a Retail Pharmacy Business To facilitate compliance with Regulations 5(1)(d), 5(1)(h) and 10 of the Regulation of Retail
Iowa District Court Polk County, Iowa. CARL OLSEN, ) ) Petitioner, ) ) vs. ) ) Docket No. CV IOWA BOARD OF PHARMACY ) ) Respondent.
Iowa District Court Polk County, Iowa CARL OLSEN, ) ) Petitioner, ) ) vs. ) ) Docket No. CV 51068 IOWA BOARD OF PHARMACY ) ) Respondent. ) MEMORANDUM IN SUPPORT OF PETITION FOR JUDICIAL REVIEW Federal
DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT
c t DRUG PRODUCT INTERCHANGEABILITY AND PRICING ACT PLEASE NOTE This document, prepared by the Legislative Counsel Office, is an office consolidation of this Act, current to September 22, 2014. It is intended
(A) A practitioner or by the practitioner's authorized agent in the practitioner's presence; or
First of 2 versions of this section 39-17-402. Definitions for this part and title 53, chapter 11, parts 3 and 4. [Effective until July 1, 2018. See the version effective on July 1, 2018.] As used in this
Legalize it? An ESL Speaking Lesson for Level Ken Peters
Legalize it? An ESL Speaking Lesson for Level 6+ Legalize it? - ESL Speaking Lesson Plan Level: 6+ Materials Required: Vocabulary Exercise handout, What do you think? handout, Poster-size paper and markers
RE: PROPOSED AMENDMENTS TO REGULATIONS TO THE CONTROLLED DRUGS AND SUBSTANCES ACT
November 8, 2017 Ms. Michelle Boudreau Director General Controlled Substances Directorate Office of Legislative and Regulatory Affairs Health Canada 150 Tunney s Pasture Driveway, Main Stats Building Address
Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative
Opioid Guardianship Project: Combating the Opioid Crisis Sarah Derr, PharmD Meg Nugent, MHA, RN Iowa Healthcare Collaborative Objectives Summarize the current crisis at the national and Iowa state level.
416 DRUG AND ALCOHOL TESTING I. PURPOSE
416 DRUG AND ALCOHOL TESTING I. PURPOSE A. The school board recognizes the significant problems created by drug and alcohol use in society in general, and the public schools in particular. The school board
EPISCOPAL DIOCESE OF ALABAMA DRUG AND ALCOHOL POLICY
EPISCOPAL DIOCESE OF ALABAMA DRUG AND ALCOHOL POLICY 1. Rules 2. Testing 3. Testing Procedure 4. Searches 5. Drug-Free Awareness 6. Discipline 7. Interpretations The Episcopal Diocese of Alabama (the Diocese)
Association of Manitoba Municipalities: 2018 Municipal Officials Seminar
Association of Manitoba Municipalities: 2018 Municipal Officials Seminar Cannabis Legalization: An Employer s Perspective Presented by: Kim Hunter and Todd Nadeau People First HR Services Full firm HR
Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
COLORADO PRESCRIPTION DRUG MONITORING PROGRAM
COLORADO PRESCRIPTION DRUG MONITORING PROGRAM Harold Rogers Prescription Drug Monitoring Program West Regional Meeting Salt Lake City, Utah August 12 13, 2014 Tia Stakely, M.S. PDMP Administrator 2005
Controlled Substance Prescribing: A Physician s Guide. Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System
Controlled Substance Prescribing: A Physician s Guide Bethanie Gamble, PharmD Department of Pharmacy Greenville Health System Objectives Review schedules of controlled substances and their propensity for
The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association
The Sale of Cannabis in Pharmacies Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association Development This activity was developed by the American Pharmacists
Assessing the Performance of FDA Risk Evaluation and Mitigation Strategies (REMS) June 30, 2015 All copyrights reserved
Assessing the Performance of FDA Risk Evaluation and Mitigation Strategies (REMS) June 30, 2015 All copyrights reserved www.biotrak.com Presentation Overview q Assessing the performance and effectiveness
Home Model Legislation Public Safety and Elections. Methamphetamine Reduction Act
Search GO LOGIN LOGOUT HOME JOIN ALEC CONTACT ABOUT MEMBERS EVENTS & MEETINGS MODEL LEGISLATION TASK FORCES ALEC INITIATIVES PUBLICATIONS NEWS Model Legislation Home Model Legislation Public Safety and
Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.
Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education
BOARD OF PHARMACY- REGULATORY UPDATE. Kimberly Grinston, J.D., Executive Director
BOARD OF PHARMACY- REGULATORY UPDATE Kimberly Grinston, J.D., Executive Director Disclosure and Conflict of Interest I declare no conflicts of interest, real or apparent, and no financial interest in any
Report for Government of Saskatchewan Cannabis Survey
Report for Government of Saskatchewan Cannabis Survey Response Counts Completion Rate: 100% Complete 26,199 Totals: 26,199 1. How should cannabis be made available for purchase in Saskatchewan? 5.1% I
This Chapter shall be known as the Marijuana Use and Regulation Ordinance for the City of Palm Desert.
PDMC SECTION: 25.34.120 Marijuana Use and Regulations This Chapter shall be known as the Marijuana Use and Regulation Ordinance for the City of Palm Desert. A. Purpose and Intent It is the purpose and
START & RUN A MARIJUANA DISPENSARY OR POT SHOP: WHEREVER IT IS LEGAL! (START & RUN A BUSINESS SERIES) BY JAY CURRIE
START & RUN A MARIJUANA DISPENSARY OR POT SHOP: WHEREVER IT IS LEGAL! (START & RUN A BUSINESS SERIES) BY JAY CURRIE DOWNLOAD EBOOK : START & RUN A MARIJUANA DISPENSARY OR POT SHOP: SERIES) BY JAY CURRIE
Americans for Better Hearing Foundation Tel: S. County Line Rd, Suite 1, Burr Ridge, IL Fax:
Non-Profit Hearing Health Foundation 501(c)(3) charitable organization. Organized in 1992 as a private Foundation to raise funding for research into hearing healthcare. Reorganized and incorporated in
Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands
Rethink. Adherence. David D. Pope, PharmD, CDE Editor-in-Chief, CreativePharmacist.com Brands Objectives Identify patient barriers to medication adherence. Describe the clinical and economic impact of
SURVEY ABOUT YOUR PRESCRIPTION CHOICES
Editor s Note: This online data supplement contains supplemental material that was not included with the published article by William Shrank and colleagues, Patients' Perceptions of Generic Medications,
TOWN OF BAY HARBOR ISLANDS PUBLIC HEARING AGENDA September 18, 2017
NOTE: A three minute maximum time limit will be imposed on all comments from the public, regardless of the subject matter. A request form is available from the Deputy Town Clerk fill it in and return it
NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference. Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement.
NYSHFA/NYSCAL 16 th Annual Nurse Leadership Conference Timothy J. Dewey Sr. Investigator NYS Bureau of Narcotic Enforcement May 2, 2018 1 May 2, 2018 2 Bureau Overview May 2, 2018 3 HISTORY 1850--Bureau
Strattera class schedule
Strattera class schedule The Borg System is 100 % Strattera class schedule The following drugs are listed as Schedule 2 (II) drugs by the Controlled Substances Act (CSA). Strattera is a selective norepinephine
Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield and
United States House of Representatives Committee on Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade Hearing on Chairwoman Bono Mack, Vice-Chairwoman Blackburn, Ranking Member Butterfield
The Role of the Responsible Pharmacist (RP)
The Role of the Responsible Pharmacist (RP) Pharmaceutical industry perspective Vuyo Mokoena: Senior Manager: Monitoring, Compliance and Professional Conduct (MCPC) Overview Background Legislative provision
Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors
Managing Risks Associated with Doctor Shopping and Other Drug-Seeking Behaviors This educational call is sponsored by the Enterprise Risk Management Task Force. Thursday, April 11, 2013 11:00 am 12:00
Nova Scotia Drug Information System
Nova Scotia Drug Information System Functions Presentation Details: Slides: 19 Duration: 00:32:04 Filename: DIS Module4.Functions.ppt Presenter Details: Slide 1 Nova Scotia Drug Information System Duration:
Changes to the Eighth Edition
Pharmacy Practice and the Law, Eighth Edition Includes Navigate 2 Advantage Access By Richard R. Abood, BS Pharm, JD-Professor Emeritus Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences,
City of San Juan Capistrano Agenda Memorandum
City of San Juan Capistrano Agenda Memorandum 9/6/2016 11 TO: FROM: Honorable Mayor and Members of the City Council Council Member Reeve DATE: September 6, 2016 SUBJECT: Consideration of a Resolution Opposing
STATUTORY INSTRUMENTS. S.I. No. 488 of 2008 REGULATION OF RETAIL PHARMACY BUSINESSES REGULATIONS 2008
STATUTORY INSTRUMENTS S.I. No. 488 of 2008 REGULATION OF RETAIL PHARMACY BUSINESSES REGULATIONS 2008 (Prn. A8/1883) 2 [488] 1. Citation. S.I. No. 488 of 2008 REGULATION OF RETAIL PHARMACY BUSINESSES REGULATIONS
Pennsylvania s Medical Marijuana Program
Pennsylvania s Medical Marijuana Program Vision The Pennsylvania Department of Health's vision is to have a high quality, efficient and compliant medical marijuana program for commonwealth residents with
Lessons from the First Year Implementing A Local Prescription Drug Abuse Coalition. Matt Willis, MD MPH Public Health Officer Marin County
Lessons from the First Year Implementing A Local Prescription Drug Abuse Coalition Matt Willis, MD MPH Public Health Officer Marin County What can we do as a community to prevent prescription drug misuse
CSS Perspective - Opioid Risk Management
Tufts Health Care Institute Program on Opioid Risk Management Risk Evaluation and Mitigation Strategy for Prescription Opioids: An In-Depth Review of Fundamental Issues CSS Perspective - Opioid Risk Management
Outline. Decreasing total opioid prescriptions Decreasing benzodiazepine and opioid co-prescription. Increasing community awareness of opioid risks
RxSafe Marin overview Outline Safe Prescribing Guidelines Decreasing total opioid prescriptions Decreasing benzodiazepine and opioid co-prescription Increasing community awareness of opioid risks Increasing
Overview. Ontario Public Drug Programs, Ministry of Health and Long-Term Care
Ontario Public Drug Programs, Ministry of Health and Long-Term Care Frequently Asked Questions for Pharmacists October 2015 Pharmacist Administration of the Publicly Funded Influenza Vaccine and Claims
DRUG AND ALCOHOL POLICY
DRUG AND ALCOHOL POLICY I. Policy Section: 6.0 Human Resources II. Policy Subsection: 6.24 Drug and Alcohol Policy III. Policy Statement Grand Rapids Community College is committed to the elimination of
Best Practices and Foundation Forum. Fred Wells Brason II
Best Practices and Foundation Forum Fred Wells Brason II fbrason@projectlazarus.org Wilkes County, NC Manual labor dominates employment options in this county of 69,000. Wilkes 4 Marvelous M s Moonshine
Conflicting Response
Conflicting Response Towards The Legalization of Recreational Marijuana Ambrose Ma, Ph.D. May 9, 2017 1 Abstract This study investigated 1) Chinese Canadians preference for or against the legalization
54% 23% 22% Administrators perceive student marijuana use is on the rise. The MassINC Polling Group 1. October 17, the same
October 17, 2017 College administrators see problems as more students view marijuana as safe Colleges look for ways to address the issue amidst changing public attitudes Public opinion on marijuana use
Guideline for the Rational Use of Controlled Drugs
Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import
Statement Of. The National Association of Chain Drug Stores. For. United States Senate Caucus on International Narcotics Control.
Statement Of The National Association of Chain Drug Stores For United States Senate Caucus on International Narcotics Control Hearing on: Improving Management 10:00 a.m. 226 Dirksen Senate Office Building
Opioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016
1 Opioid Abuse in Iowa Rx to Heroin Iowa Governor s Office of Drug Control Policy January 2016 Why Is This Important? 2 3 National Rx Painkiller Trends CDC, 2013 4 National Rx-Heroin Trends NIH, 2015 5
Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.
Prescribing and Dispensing Profile Tennessee Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points
ADVERTISING - CALIFORNIA
MEDICAL MARIJUANA ADVERTISING - CALIFORNIA ADVERTISING - ARIZONA STATE LEGISLATION Number of dispensaries Statewide 1 for every 10 pharmacies, Estimated 124 County (minimum 1) City (estimated 3 5) Agents
[First Reprint] ASSEMBLY, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 4, 2016
![[First Reprint] ASSEMBLY, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 4, 2016](/thumbs/86/93824414.jpg "[First Reprint] ASSEMBLY, No STATE OF NEW JERSEY. 217th LEGISLATURE INTRODUCED FEBRUARY 4, 2016")
[First Reprint] ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 0 Sponsored by: Assemblyman DANIEL R. BENSON District (Mercer and Middlesex) Assemblywoman VALERIE VAINIERI HUTTLE
Confronting the Opioid Crisis at the State Level
Confronting the Opioid Crisis at the State Level The webinar has not yet begun. Audio will be available through the call-in information contained in your registration confirmation e-mail. Moderator: May
Amending Your Land Use Bylaw To Prepare For The Retail Sale Of Cannabis
1 Amending Your Land Use Bylaw To Prepare For The Retail Sale Of Cannabis The Federal Government has proposed that by July 2018 non -medical cannabis will be legalized in Canada. Currently, cannabis possession
COMMON REFERRAL FORM
DISTRICT OF NIPISSING COMMUNITY MENTAL HEALTH AND ADDICTIONS LONG TERM SUPPORT SERVICES COMMON REFERRAL FORM Assertive Community Treatment Teams 1 and 2, North Bay Regional Health Centre ACTT 1 Phone 705-494-3031
Application for Special Licence (for premises)
District Office 15 Galileo Street Private Bag 544 Ngaruawahia 3742 Huntly Area Office 142 Main Street 0800 492 452 Raglan Area Office 7 Bow Street 07 825 8129 Tuakau Area Office 2 Dominion Road 0800 492